Physician profile
Kevin Danieles
NPI 1689390403
$317.41
in general payments reported to CMS, 2019-2025
10 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.25 · 2023: $45.65 · 2024: $115 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.21 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $99.95 | 2024 | |
| Sobi, INC | $60.20 | 2025 | |
| Novartis Pharmaceuticals Corporation | $34.36 | 2025 | |
| Abbvie INC. | $25.25 | 2022 | |
| Taiho Oncology, INC. | $20.52 | 2025 | |
| Merck Sharp & Dohme LLC | $17.05 | 2023 | Keytruda |
| Glaxosmithkline, LLC. | $16.93 | 2025 | Ojjaara |
| Mirati Therapeutics, INC. | $14.55 | 2024 | Krazati |
| Pharmacyclics LLC, An Abbvie Company | $14.54 | 2023 | Imbruvica |
| Amgen INC. | $14.06 | 2023 | Nplate, Vectibix, Xgeva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Danieles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.